key: cord-0778513-kuaishfn
authors: Goldberg, Alan B.; Kyung, Stella; Swearingen, Sean; Rao, Anupama
title: Expecting the unexpected: Echo laboratory preparedness in the time of COVID‐19
date: 2020-07-13
journal: Echocardiography
DOI: 10.1111/echo.14763
sha: ad85fcbf6f7a96bb19659e41123a23dee4baf098
doc_id: 778513
cord_uid: kuaishfn

COVID‐19 poses a unique set of challenges to the healthcare system due to its rapid spread, intensive resource utilization, and relatively high morbidity and mortality. Healthcare workers are at especially high risk of exposure given the viruses spread through close contact. Reported cardiac complications of COVID‐19 include myocarditis, acute coronary syndrome, cardiomyopathy, pericardial effusion, arrhythmia, and shock. Thus, echocardiography is integral in the timely diagnosis and clinical management of COVID‐19 patients. Rush University Medical Center has been at the forefront of the COVID‐19 response in Illinois with high numbers of cases reported in Chicago and surrounding areas. The echocardiography laboratory at Rush University Medical Center (RUMC) proactively took numerous steps to balance the imaging needs of a busy, nearly 700‐bed academic medical center while maintaining safety.

F I G U R E 1 Healthcare workers, and medical sonographers in particular, are at the greatest risk of COVID-19 due to daily exposure to the virus and work in close proximity to patients, based on data compiled by the United States Department of Labor F I G U R E 2 Cardiologist, Dr Anupama Rao, MD, wearing full personal protective equipment including continuous airpurifying respirator (CAPR) prior to performing a TEE on a COVID + patient in the intensive care unit However, in response to the global pandemic, additional measures were enacted to screen and prioritize studies.

To preserve limited hospital resources and protect personnel, all nonurgent, elective outpatient noninvasive testing including transthoracic echocardiogram (TTE), transesophageal echocardiogram (TEE), and stress echocardiography studies were postponed beginning March 15, 2020. This decision predated Chicago's closure of public schools by 2 days and the city's stay at home order by 8 days. 6 While these studies were initially rescheduled for 4 weeks, they are now postponed indefinitely until the COVID-19 hospital surges have been sufficiently mitigated. Urgent outpatient studies, such as prechemotherapy initiation or presurgery, are scheduled on an individual basis after discussion between the ordering provider and the echocardiography attending of the day. Fig S1) .

Inpatient TEEs have also been screened in line with the ASE recommendations. 8 Indications for POCUS include significant troponin elevation, new cardiac abnormality on radiographic imaging, concern for shock, new heart failure, persistent arrhythmia, and/or significant ECG changes. 10 If any new abnormalities are identified on POCUS, a sonographer-performed TTE is typically recommended. Finally, for all echocardiograms ordered on PUI and confirmed cases at RUMC, the performing sonographer is assigned a "buddy."

The rationale for a "buddy system" is multifaceted. The TTE buddy helps ensure proper PPE use: checking that the mask and goggles have a good seal and that the gown is tied properly. While the 

Recognizing that prolonged exposure to COVID-19 positive increases the risk of viral transmission, at RUMC all echocardiograms, after appropriate screening, are defaulted to limited studies. When possible, the chart is reviewed to understand the clinical picture and the ordering physician is involved to ascertain the key questions that can be answered by TTE. In the majority of cases, left ventricular ejection fraction (LVEF), regional wall-motion abnormalities, right Transesophageal echocardiogram studies are also focused to limit personnel exposure time, while adequately providing pertinent information to answer the clinical question.

To further ensure sonographer safety, TTE scan times are measured for each study and tracked longitudinally for each sonographer.

With these data, an individual's length of exposure can be accurately tracked and scanning time can be adjusted to ensure equity. This step is especially important for higher risk individuals, such as those with preexisting conditions, pregnancy, or age >60. Since implementation, the average scan duration has decreased 28% ( Figure 6 ).

A successful echocardiography laboratory must provide high-quality, timely, and clinically relevant cardiovascular imaging regardless of the circumstances. However, the COVID-19 pandemic has also highlighted the importance of implementing policies and procedures that prioritize the safety of sonographers and all echo laboratory personnel without diminishing quality. At RUMC, several important steps included postponing elective procedures, expanding the role of POCUS, thoroughly vetting inpatient studies, properly protecting equipment and staff, encouraging teamwork, limiting exposure by adjusting study parameters, and quantifying exposure to mitigate risk. Together, these initiatives will hopefully improve patient care and ensure staff well-being. At the time of publication, zero sonographers, cardiology attendings, or cardiology fellows have tested F I G U R E 6 Scan time data (left) collected for COVID-19 patients. Average scan times decreased by over 4 min after initiation of data collection (right) positive for COVID-19; only symptomatic employees have been tested in accordance with institutional policy. The scope of this article is limited to echo laboratory best practices during the pandemic.

Future studies will evaluate the utility and use of performing limited TTEs and POCUS in patients with COVID-19, specifically in regard to adverse patient outcomes and correlation with biomarkers. 

WHO Timeline -COVID-19

COVID-19) -Google News

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

?auth=linke d-googl e1tap &fbcli d=IwAR0 XrEUC a0RBk sEVIn rPIHn vqv17 2QXx-7pgCK Up5lg YVjgN LgDEZ 5saeN g&smid=fb-share

Coronavirus disease 2019 (COVID-19) and cardiovascular disease

ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak

Specific considerations for the protection of patients and echocardiography service providers when performing perioperative or periprocedural transesophageal echocardiography during the 2019 novel coronavirus outbreak: council on perioperative echocardiography supplement to the statement of the American society of echocardiography

Recommendations for echocardiography laboratories participating in cardiac point of care cardiac ultrasound (POCUS) and critical care echocardiography training: report from the american society of echocardiography

Cardiology -COVID-19 protocols

Infection Control: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | CDC

Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards